RENB RENOVARO INC Management Changes 8-K Filing 2024 - Appointment of Interim CFO Enochian Biosciences Inc appointed Simon Tarsh as Interim Chief Financial Officer and entered into a consulting agreement with Tarsh PB Advisors.Get access to all SEC 8-K filings of the RENOVARO INC